TECR - TechCare Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1194
0.0000 (0.00%)
At close: 10:04AM EDT
Stock chart is not supported by your current browser
Previous Close0.1194
Open0.1194
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1194 - 0.1194
52 Week Range0.0400 - 0.4120
Volume11
Avg. Volume5,564
Market Cap4.234M
Beta (3Y Monthly)4.29
PE Ratio (TTM)N/A
EPS (TTM)-0.0710
Earnings DateNov 11, 2019 - Nov 19, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire

    TechCare Entered Into Joint Venture Contract With China-Israel Biological Technology Co. Ltd.

    NEW YORK, Jan. 29, 2019 /PRNewswire/ -- TechCare Corp. (TECR), a technology company with a revolutionary delivery platform that uses vapor technology for natural health, wellness and beauty treatments, today announced that on January 21, 2019, it entered into a joint venture contract with China-Israel Biological Technology Co. Ltd. ("CIB"). Pursuant to the agreement, TechCare's subsidiary, Novomic Ltd. ("Novomic") and CIB agreed to form a Chinese joint venture company in China ("JV").

  • PR Newswire

    TechCare Appoints Tali Dinar, Former MICT Inc. as Its Chief Financial Officer

    TechCare Corp. (TECR), a technology company with a revolutionary delivery platform that uses vapor technology for natural health, wellness and beauty treatments, today announced that it appointed Tali Dinar, former MICT Inc. executive, as its new Chief Financial Officer. Dinar holds a BA in Accounting and Business Administration from the College of Management Academic Studies, Israel.

  • TechCare Appoints Osnat Philipp, Former Lumenis, P&G and Teva Pharmaceuticals Executive, as Chief Executive Officer of Novomic
    PR Newswire

    TechCare Appoints Osnat Philipp, Former Lumenis, P&G and Teva Pharmaceuticals Executive, as Chief Executive Officer of Novomic

    NEW YORK, Jan. 15, 2019 /PRNewswire/ -- TechCare Corp. (TECR), a technology company with a revolutionary delivery platform that uses vapor technology for natural health, wellness and beauty treatments, today announced that it appointed Osnat Philipp, former Lumenis, P&G and Teva Pharmaceuticals executive, as Chief Executive Officer of its wholly owned subsidiary, Novomic Ltd.